Minoxidil Plus product seizure Aug. 3 is latest action in long-running case of Upjohn v. Medtron.
Executive Summary
MINOXIDIL PLUS PRODUCT SEIZURE AUG. 3 IN NEW YORK CITY is the latest action in a long-running legal effort by Upjohn to bar a Manhattan salon from capitalizing on Rogaine labeling for treatment of hair loss. The seizure of "Minoxidil Plus" came after Manhattan federal court Judge Shirley Wohl Kram ruled July 19 that the Hair & Skin Treatment Center (formerly New York Hair Labs, formerly Medtron) was in contempt of the court's 1990 and 1992 injunctions enjoining the defendant from the "manufacturing, sale, distribution, advertisement, and promotion" of products covered by Upjohn's Rogaine patents.